Literature DB >> 11755136

Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine.

R H Wang1, D Schorer-Apelbaum, M Weinstock.   

Abstract

The fall in body temperature and inhibition of hypothalamic cholinesterase induced by rivastigmine (a pseudo-reversible carbamate inhibitor) were compared in male and female rats. In males, 1.5 mg/kg lowered body temperature by 1 degrees C and in females by 3.2 degrees C (P<0.001) and inhibited cholinesterase by 65% and 74%, respectively (P<0.05). Pilocarpine (20 mg/kg) decreased body temperature by 1.1 degrees C in males and 1.9 degrees C in females (P<0.05). Orchidectomy, but not ovariectomy, abolished the sex difference in the hypothermic effect of pilocarpine and the enzyme inhibition induced by rivastigmine, but not in its effect on body temperature. Testosterone (10 mg/rat) decreased the cholinesterase inhibition and the temperature reduction induced by rivastigmine in gonadectomised males and females, but that induced by pilocarpine in males only. In conclusion, rivastigmine causes less inhibition of cholinesterase because testosterone may interfere with its entry into the brain. Testosterone may further decrease the temperature-lowering effect of rivastigmine and acetylcholine receptor agonists in males by an action at a receptor level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755136     DOI: 10.1016/s0014-2999(01)01498-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression.

Authors:  Michelle M Mielke; Jeannie-Marie Leoutsakos; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; JoAnn T Tschanz; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012-02-01       Impact factor: 21.566

2.  Pharmacokinetics and pharmacodynamics of chlorpyrifos in male and female cattle after topical administration.

Authors:  Eduardo J Picco; Marcelo R Rubio; Diego C Díaz David; Casilda Rodríguez; Juan C Boggio
Journal:  Vet Res Commun       Date:  2008-02-12       Impact factor: 2.459

3.  Sex differences in behavioral outcomes following temperature modulation during induced neonatal hypoxic ischemic injury in rats.

Authors:  Amanda L Smith; Haley Garbus; Ted S Rosenkrantz; Roslyn Holly Fitch
Journal:  Brain Sci       Date:  2015-05-22

4.  Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease.

Authors:  Balmiki Ray; Bryan Maloney; Kumar Sambamurti; Hanuma K Karnati; Peter T Nelson; Nigel H Greig; Debomoy K Lahiri
Journal:  Transl Psychiatry       Date:  2020-02-03       Impact factor: 6.222

5.  Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.

Authors:  Virginia M Miller; Vesna D Garovic; Kejal Kantarci; Jill N Barnes; Muthuvel Jayachandran; Michelle M Mielke; Michael J Joyner; Lynne T Shuster; Walter A Rocca
Journal:  Biol Sex Differ       Date:  2013-03-28       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.